Julian Levell, Ph.D.

Julian Levell is Head of Discovery with responsibility for all small molecule discovery research. Julian carried out his Ph.D. research at Cardiff University on the molecular tailoring of organic photochromic molecules, followed by postdoctoral research at University of Florida on the development of novel heterocyclic chemistry methodology. He has worked in biotech and pharma research for 25 years, having previously spent time at Centaur Pharmaceuticals, Rhone-Poulenc Rorer/Aventis (Sanofi), the Novartis Institutes for Biomedical Research and Constellation Pharmaceuticals. During his career, Julian has led teams and projects across multiple disease areas including cardiovascular, diabetes, asthma, neuroscience, and oncology; with numerous programs transitioning through IND. Julian has over 50 patents and publications, and is a core member of the NIH National Cancer Institutes (NCI) Experimental Therapeutics (NExT) review committee and Special Emphasis Panel (SEP). In his spare time he enjoys running, skiing and scuba diving.